{
    "clinical_study": {
        "@rank": "26862", 
        "arm_group": [
            {
                "arm_group_label": "Arm I (print educational intervention)", 
                "arm_group_type": "Experimental", 
                "description": "Participants undergo a print educational intervention during which they meet with a site coordinator and are instructed to read the NCI booklet titled Taking Part in Cancer Treatment Studies, comprised primarily of information about the nature and conduct of cancer clinical trials."
            }, 
            {
                "arm_group_label": "Arm II (multimedia psychoeducational intervention)", 
                "arm_group_type": "Experimental", 
                "description": "Participants undergo a multimedia psychoeducational intervention during which they meet with a site coordinator and are instructed to view a DVD and read a booklet titled Clinical Trials: Are They Right For You? Participants are encouraged to watch the DVD and read the booklet again at home."
            }
        ], 
        "brief_summary": {
            "textblock": "This randomized clinical trial compares multimedia psychoeducation to print education in\n      preparing patients with cancer for decision making about clinical trial participation.\n      Multimedia psychoeducation includes a DVD and written materials with a combined focus on\n      knowledge and attitude change, and may be an effective method to help patients prepare for\n      decision making about clinical trial participation. It is not yet known whether a multimedia\n      psychoeducation is more effective than print education in preparing patients for decision\n      making about clinical trials."
        }, 
        "brief_title": "Multimedia Psychoeducation or Print Education in Preparing Patients With Cancer for Decision Making About Clinical Trial Participation", 
        "condition": "Malignant Neoplasm", 
        "condition_browse": {
            "mesh_term": "Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "PRIMARY OBJECTIVES:\n\n      I. To determine the effect of intervention assignment on patients' preparedness for decision\n      making about clinical trial participation.\n\n      SECONDARY OBJECTIVES:\n\n      I. To determine the effect of intervention assignment on indicators of the quality of\n      patients' decision making about clinical trial participation.\n\n      II. To examine mechanisms by which multimedia psychoeducation (MP) exerts its expected\n      positive effects on preparedness for decision making.\n\n      TERTIARY OBJECTIVES:\n\n      I. To explore the effects of intervention assignment on clinical trial participation.\n\n      OUTLINE: Participants are randomized to 1 of 2 arms.\n\n      ARM I: Participants undergo a print educational intervention during which they meet with a\n      site coordinator and are instructed to read the National Cancer Institute (NCI) booklet\n      titled Taking Part in Cancer Treatment Studies, comprised primarily of information about the\n      nature and conduct of cancer clinical trials.\n\n      ARM II: Participants undergo a multimedia psychoeducational intervention during which they\n      meet with a site coordinator and are instructed to view a digital video disk (DVD) and read\n      a booklet titled Clinical Trials: Are They Right For You? Participants are encouraged to\n      watch the DVD and read the booklet again at home.\n\n      After completion of study, patients are followed up at 3-7 and 49-56 days."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Be able to speak and read English\n\n          -  Be diagnosed with cancer\n\n          -  Have been determined to be eligible for a specific phase II or III therapeutic\n             clinical trial open for enrollment at the participating Community Clinical Oncology\n             Program (CCOP) site\n\n          -  Have been informed of their eligibility for a specific phase II or III therapeutic\n             clinical trial\n\n          -  Be capable of providing written informed consent for study participation\n\n        Exclusion Criteria:\n\n          -  Participants must not have been asked previously to participate in another\n             therapeutic cancer clinical trial\n\n          -  Participants must not have already made a decision to participate in the phase II or\n             III therapeutic clinical trial for which they were informed of their eligibility\n\n          -  Participants must not have documented or observable visual, auditory, psychiatric, or\n             neurological disorders that would interfere with study participation (e.g.,\n             blindness, deafness, psychosis, or dementia)\n\n          -  Participants must not be eligible only for phase I trial; these patients are excluded\n             because few of these trials are offered at CCOP sites and because their design and\n             goals differ considerably from those of phase II and III trials"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "392", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 31, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02054715", 
            "org_study_id": "URCC12107", 
            "secondary_id": [
                "NCI-2013-02237", 
                "URCC12107", 
                "URCC-12107", 
                "U10CA037420"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "Arm I (print educational intervention)", 
                "description": "Undergo print educational intervention", 
                "intervention_name": "educational intervention", 
                "intervention_type": "Other", 
                "other_name": "intervention, educational"
            }, 
            {
                "arm_group_label": "Arm II (multimedia psychoeducational intervention)", 
                "description": "Undergo multimedia psychoeducational intervention", 
                "intervention_name": "educational intervention", 
                "intervention_type": "Other", 
                "other_name": "intervention, educational"
            }, 
            {
                "arm_group_label": [
                    "Arm I (print educational intervention)", 
                    "Arm II (multimedia psychoeducational intervention)"
                ], 
                "description": "Ancillary studies", 
                "intervention_name": "questionnaire administration", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 6, 2014", 
        "location": [
            {
                "contact": {
                    "email": "kwells@mail.sdsu.edu", 
                    "last_name": "Kristen Wells", 
                    "phone": "619-594-1919"
                }, 
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92182"
                    }, 
                    "name": "San Diego State University"
                }, 
                "investigator": {
                    "last_name": "Kristen Wells", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "paul.jacobsen@moffitt.org", 
                    "last_name": "Paul Jacobsen", 
                    "phone": "585-275-5513"
                }, 
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33612"
                    }, 
                    "name": "H. Lee Moffitt Cancer Center and Research Institute"
                }, 
                "investigator": {
                    "last_name": "Paul Jacobsen", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Joseph Leach, MD", 
                    "phone": "952-993-1516"
                }, 
                "facility": {
                    "address": {
                        "city": "Minneapolis", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55426"
                    }, 
                    "name": "Metro MN CCOP"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Alan P Lys, MD", 
                    "phone": "314-996-5569"
                }, 
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63131"
                    }, 
                    "name": "Heartland CCOP"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Gary_morrow@urmc.rochester.edu", 
                    "last_name": "Gary R. Morrow", 
                    "phone": "585-275-5513"
                }, 
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "14642"
                    }, 
                    "name": "University of Rochester"
                }, 
                "investigator": {
                    "last_name": "Gary R. Morrow", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Philip Kuebler, MD", 
                    "phone": "614-488-3320"
                }, 
                "facility": {
                    "address": {
                        "city": "Columbus", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "43215"
                    }, 
                    "name": "Columbus CCOP"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jgiguere@ghs.org", 
                    "last_name": "Jeffrey K. Giguere", 
                    "phone": "864-241-6251"
                }, 
                "facility": {
                    "address": {
                        "city": "Greenville", 
                        "country": "United States", 
                        "state": "South Carolina", 
                        "zip": "29615"
                    }, 
                    "name": "Greenville Health System Cancer Instutite/Greenville CCOP"
                }, 
                "investigator": {
                    "last_name": "Jeffrey K. Giguere", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "weiss.matthias@marshfieldclinic.org", 
                    "last_name": "Matthias Weiss", 
                    "phone": "715-389-4772"
                }, 
                "facility": {
                    "address": {
                        "city": "Marshfield", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "54449"
                    }, 
                    "name": "Marshfield Clinic"
                }, 
                "investigator": {
                    "last_name": "Matthias Weiss", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Evaluation of Psychoeducation for Cancer Patients Eligible for Clinical Trials", 
        "other_outcome": {
            "description": "Data for all patients offered participation in a therapeutic clinical trial will be entered into a 2 (Intervention: MP or paper education [PE]) x 2 (Clinical Trial Participation: Yes or No/Still Deciding) contingency table and analyzed using either a Fisher exact test or chi-square test as appropriate.", 
            "measure": "Clinical trial participation rates", 
            "safety_issue": "No", 
            "time_frame": "Up to day 56"
        }, 
        "overall_official": {
            "affiliation": "University of Rochester", 
            "last_name": "Paul Jacobsen", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Individual CCOP site effects will be examined by plotting the Empirical Best Linear Unbiased Predictions. All potential confounding variables will be adjusted for in the analysis as fixed effects. Restricted likelihood tests will be used to test the random effects, and F-tests based on the Kenward-Roger procedure will be used to test the fixed effects.", 
            "measure": "Preparedness for decision making about clinical trial participation, measured using scores from the Preparation for Decision Making Scale", 
            "safety_issue": "No", 
            "time_frame": "Up to day 56"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02054715"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Rochester", 
            "investigator_full_name": "Gary Morrow", 
            "investigator_title": "Director, URCC CCOP Research Base", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Individual CCOP site effects will be examined by plotting the Empirical Best Linear Unbiased Predictions. All potential confounding variables will be adjusted for in the analysis as fixed effects. Restricted likelihood tests will be used to test the random effects, and F-tests based on the Kenward-Roger procedure will be used to test the fixed effects.", 
                "measure": "Quality of decision making based on decisional conflict and decisional regret measured using total scores on the decisional conflict scale", 
                "safety_issue": "No", 
                "time_frame": "Up to day 56"
            }, 
            {
                "description": "Mediational analyses will be conducted if, as expected, intervention assignment is significantly associated with decision quality as measured by the total score on the Decision Conflict Scale. Path coefficients for the mediator model and bootstrap confidence intervals for effects will be estimated to determine the significance of a potential mediator using methods described by Preacher and Hayes. Estimation (using MPlus Version 6 or later) will be through Full Information Maximum Likelihood using the bootstrap procedure to obtain standard errors and 95% confidence intervals.", 
                "measure": "Attitudes regarding clinical trial participation", 
                "safety_issue": "No", 
                "time_frame": "Up to day 56"
            }, 
            {
                "description": "Mediational analyses will be conducted if, as expected, intervention assignment is significantly associated with decision quality as measured by the total score on the Decision Conflict Scale. Path coefficients for the mediator model and bootstrap confidence intervals for effects will be estimated to determine the significance of a potential mediator using methods described by Preacher and Hayes. Estimation (using MPlus Version 6 or later) will be through Full Information Maximum Likelihood using the bootstrap procedure to obtain standard errors and 95% confidence intervals.", 
                "measure": "Self-efficacy regarding clinical trial participation", 
                "safety_issue": "No", 
                "time_frame": "Up to day 56"
            }
        ], 
        "source": "University of Rochester", 
        "sponsors": {
            "collaborator": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "University of Rochester", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}